Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Dihydropyridine action on voltage-dependent potassium channels expressed in Xenopus oocytes.
Avdonin V
,
Shibata EF
,
Hoshi T
.
???displayArticle.abstract???
Dihydropyridines (DHPs) are well known for their effects on L-typed voltage-dependent Ca2+ channels, However, these drugs also affect other voltage-dependent ion channels, including Shaker K+ channels. We examined the effects of DHPs on the Shaker K+ channels expressed in Xenopus oocytes. Intracellular applications of DHPs quickly and reversibly induced apparent inactivation in the Shaker K+ mutant channels with disrupted N- and C-type inactivation. We found that DHPs interact with the open state of the channel as evidenced by the decreased mean open time. The DHPs effects are voltage-dependent, becoming more effective with hyperpolarization. A model which involves binding of two DHP molecules to the channel is consistent with the results obtained in our experiments.
Figure 2. (A) Nifedipine applied externally is less effective in
blocking the ionic currents through the ShBÎ6-46 T449V channel.
Peak amplitudes of the currents measured using the two-electrode
voltage clamp during voltage pulses from â100 mV to +50 mV are
plotted (filled circles: data measured during nifedipine (100 μM)
application, open circles: wash out of drug). Representative current
sweeps recorded at the end of the corresponding segment are
shown in inset. (B) Nifedipine, exposed to ultraviolet light, is less
effective in blocking the ShBÎ6-46 T449V current. Representative
inside-out macro-patch currents in response to pulses from â100
mV to +50 mV. A half of the nifedipine solution (50 μM) was
treated with UV light (254 nm 18W for 90 min at 1 cm) and the efficacy of the UV-treated nifedipine was compared with the other
half of the nifedipine solution, which did not receive UV treatment.
Figure 3. Block of the ShBÎ6-46 T449V macroscopic currents by
different DHPs. Currents were recorded in the inside-out configuration in response to depolarizing voltage steps to 0 mV. Indicated
DHPs were applied to the internal side. The concentration was 100
μM for all DHPs.
Figure 4. Concentration dependence of DHP block of the macroscopic currents through the ShBÎ6-46 T449V channels. (A) Current traces obtained in response to voltage steps to +50 mV with
the indicated concentrations of nifedipine in the internal solution.
(B) Hill plot of the concentration dependence of block of ShBÎ6-46 T449V channel by nimodipine (open circles) and nifedipine
(closed circles). Block is given by Idrug/Icontrol. Dashed lines are the
least square fits of the data with Hill equation. Both nifedipine and
nimodipine fits give a Hill coefficient value of 1.5. (C) Relative reduction of the steady state current measured at the end of a 200-ms voltage pulse to +50 mV by different concentrations of nifedipine. Values on the vertical axis were calculated as 1-Inifedipine/
Icontrol. Data points represent mean ± standard deviation of six experiments. (D) Time constants of the current decline induced by
nifedipine block. The currents elicited by 200-ms voltage pulses to
+50 mV in the presence of nifedipine at the concentrations indicated were fitted with a sum of two exponentials. (E) Relative reduction of the steady-state current by nimodipine. The data were
collected and analyzed as in C. (F) Time constants of the current
decline in the presence of nimodipine (averages of four to seven
experiments). The data were collected and analyzed as in D. In BâF,
smooth curves show least square fits of the data obtained from the
simulated currents as described in discussion (thin line, scheme SII,
thick line, scheme SV).
Figure 5. Nifedipine decreases the mean open time in ShBÎ6-46
T449V:A463I. (A) Representative openings in the absence (upper
traces) and in presence of 100 μM nifedipine (lower traces) in the internal solution. Inside-out configuration at 0 mV. Closed state is indicated by dashed line. The data were filtered at 1.8 kHz. The
patch contained one functional channel. (B) Open time histograms with and without 100 μM nifedipine. Data are shown in
square root scaling on vertical axis (Sigworth and Sine, 1987). Single exponential fits are shown superimposed. (C) Reciprocals of
the mean open times at several concentrations of nifedipine. Each
data point represents the mean ± standard deviation of four to six
experiments. Solid line shows linear least square fit of first three
points.
Figure 6. Nifedipine effects on the closed time distribution of
ShBÎ6-46 T449V:A463I. Closed time distributions in the absence
(A) and in the presence (B) of 100 μM nifedipine. Data are shown
in square root scaling on vertical axis. Lines shown represent four
exponential fits of the distributions. Under control conditions the
time constants (fractional amplitudes) were 0.2 ms (0.871), 2.1 ms
(0.097), 16.8 ms (0.029), and 352 ms (0.003). For nifedipine, the
three time constants (fractional amplitudes) were 0.2 ms (0.84),
5.7 ms (0.048), and 26 ms (0.109).
Figure 7. Nifedipine block in presence of either N- or C-type inactivation. (A) Internal TEA and N-type inactivation compete. The
ShD currents obtained with and without internal TEA (2 mM) are
shown at the top and the scaled currents are shown below. The
scaled currents show a cross-over. (B) Nifedipine block of the macroscopic currents through ShD channels. (C) Macroscopic currents through the ShBÎ6-46 T449K channels with C-type inactivation (control and 100 μM nifedipine). Scaled currents (lower
traces) show that the current in the presence of nifedipine inactivates faster. (D) Time constants of ShBÎ6-46 T449K current decline in control and in the presence of 100 μM nifedipine in internal solution. The current traces were fitted with a sum of two exponentials. Each point represents mean ± standard deviation of 12
experiments (Control) or 8 experiments (Nifedipine). (E) Nifedipine
block (50 μM) of the ShBÎ6-46 T449V currents without N- or
C-type inactivation recorded with different external K+ concentrations. The currents were elicited by depolarizing pulses to +50 mV.
Figure 8. Voltage dependence of DHP block. The currents were
first elicited by voltage pulses to +50 mV followed by voltage steps
to â20 to +90 mV in 10 mV increments. (A) The ShBÎ6-46 T449V
channels do not show significant relaxation after the voltage
change. (B) Slow relaxations of the macroscopic currents through
the ShBÎ6-46 T449V channels in presence of 25 μM nimodipine.
The currents relaxed to lower values at voltages more negative
than +50 mV showing more effective block of nimodipine at these
voltages. (C) Same as B in presence of 100 μM nifedipine. (D)
Voltage-dependent relaxation of the ShBÎ6-46 T449V:A463I current with 100 μM nifedipine. (E) Voltage dependence of the block
for ShBÎ6-46 T449V in the presence of 25 μM (diamonds) and 50
μM (circles) of nifedipine. Relative block was calculated as a ratio of
the current value immediately after the voltage change over the
current value after relaxation based on the single exponential fit of
the current decline. The data sets were fitted with function exp
[nâe (V â 50) / k T] to obtain number of equivalent charges n. (Fâ)
Concentration dependence of the equivalent charges associated
with the voltage dependence of the block obtained as described in
E for nifedipine block of the ShBÎ6-46 T449V current (circles),
ShBÎ6-46 T449V:A463I current (squares), and nimodipine block of
ShBÎ6-46 T449V current (triangles). Solid lines represent the
scheme SV predictions of nifedipine (upper line) and nimodipine
(lower line) block equivalent charges. The model predictions were
calculated using the blocking rate constants obtained from the
concentration dependence data shown in Fig. 4. Data points represent mean ± standard deviation of five to eight experiments.
Figure 9. Nifedipine block does not depend on the current flow
direction. (A) Macroscopic currents through the ShBÎ6-46 T449V
channels (control and 100 μM nifedipine) at +30 mV. Outward
currents were obtained with 140 mM K+out / 140 mM K+in, and the
inward currents with 140 mM K+out/ no internal K+ (substituted
with NMG). (B) Comparison of nifedipine block (100 μM) at various voltages with high K+ (140 mM) inside (circles) and no K+ ions
inside (squares). External K+ concentration was 140 mM in both
cases. Data points show the fraction of unblocked current at the
end of 200-ms voltage pulse to the voltages indicated (mean ±
standard deviation of five experiments).
Figure 10. Differential effects of nifedipine on the ShBÎ6-46
T449V and ShBÎ6-46 T449V:A463I channels. (A) Effects of nifedipine (100 μM) on the macroscopic currents recorded at +50
mV from ShBÎ6-46 T449V (top) and ShBÎ6-46 T449V:A463I (bottom). (B) Comparison of the concentration dependence of nifedipine block of the ShBÎ6-46 T449V (circles) and ShBÎ6-46 T449V:
A463I (squares) currents. Solid line represents the model prediction of scheme SV for ShBÎ6-46 T449V:A463I. Values of the block
constants of nifedipine for ShBÎ6-46 T449V were used in simulation. ShBÎ6-46 T449V:A463I was simulated by stabilizing the open
state in scheme SI by 1.3 kcal/mol (see discussion). Each data
point represents mean ± standard deviation of six to nine experiments. (C) Scaled tail currents obtained at â100 mV for ShBÎ6-46
T449V and at â120 mV for ShBÎ6-46 T449V:A463I after pulses to
+50 mV with 140 mM K+ out. Nifedipine (100 μM) slowed the tail
current in ShBÎ6-46 T449V and accelerated in ShBÎ6-46 T449V:
A463I.
Baukrowitz,
Use-dependent blockers and exit rate of the last ion from the multi-ion pore of a K+ channel.
1996, Pubmed
Baukrowitz,
Use-dependent blockers and exit rate of the last ion from the multi-ion pore of a K+ channel.
1996,
Pubmed
Bezanilla,
Gating of Shaker K+ channels: II. The components of gating currents and a model of channel activation.
1994,
Pubmed
,
Xenbase
Choi,
Tetraethylammonium blockade distinguishes two inactivation mechanisms in voltage-activated K+ channels.
1991,
Pubmed
Demo,
The inactivation gate of the Shaker K+ channel behaves like an open-channel blocker.
1991,
Pubmed
Glossmann,
Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.
1984,
Pubmed
Gotoh,
Inhibition of transient outward K+ current by DHP Ca2+ antagonists and agonists in rabbit cardiac myocytes.
1991,
Pubmed
Grabner,
Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.
1996,
Pubmed
Hamill,
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
1981,
Pubmed
Hess,
Calcium channels in vertebrate cells.
1990,
Pubmed
Hoshi,
Two types of inactivation in Shaker K+ channels: effects of alterations in the carboxy-terminal region.
1991,
Pubmed
,
Xenbase
Hoshi,
Shaker potassium channel gating. I: Transitions near the open state.
1994,
Pubmed
,
Xenbase
Hoshi,
Biophysical and molecular mechanisms of Shaker potassium channel inactivation.
1990,
Pubmed
,
Xenbase
Jacobs,
Mechanisms of potassium channel block in rat alveolar epithelial cells.
1990,
Pubmed
Kirsch,
Segmental exchanges define 4-aminopyridine binding and the inner mouth of K+ pores.
1993,
Pubmed
López-Barneo,
Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels.
1993,
Pubmed
,
Xenbase
Ludewig,
A site accessible to extracellular TEA+ and K+ influences intracellular Mg2+ block of cloned potassium channels.
1993,
Pubmed
Methfessel,
Patch clamp measurements on Xenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels.
1986,
Pubmed
,
Xenbase
Nakayama,
Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.
1991,
Pubmed
Regulla,
Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel alpha 1 subunit.
1991,
Pubmed
Reuter,
Calcium channels in the heart. Properties and modulation by dihydropyridine enantiomers.
1988,
Pubmed
Sigworth,
Data transformations for improved display and fitting of single-channel dwell time histograms.
1987,
Pubmed
Stefani,
Gating of Shaker K+ channels: I. Ionic and gating currents.
1994,
Pubmed
,
Xenbase
Timpe,
Four cDNA clones from the Shaker locus of Drosophila induce kinetically distinct A-type potassium currents in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
Triggle,
Ca2+ channel ligands: structure-function relationships of the 1,4-dihydropyridines.
1989,
Pubmed
Yatani,
Effects of dihydropyridine calcium channel modulators on cardiac sodium channels.
1988,
Pubmed
Zagotta,
Shaker potassium channel gating. III: Evaluation of kinetic models for activation.
1994,
Pubmed
,
Xenbase
Zagotta,
Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB.
1990,
Pubmed
,
Xenbase
Zagotta,
Shaker potassium channel gating. II: Transitions in the activation pathway.
1994,
Pubmed
,
Xenbase
Zhorov,
Structural model of a synthetic Ca2+ channel with bound Ca2+ ions and dihydropyridine ligand.
1996,
Pubmed